Jacobio Pharmaceuticals Co., Ltd.

This is an early-stage study to test the safety and find the right dose of a new experimental drug, JAB-8263, in adults with advanced cancers that have not responded to standard treatments. The trial will enroll about 152 people with various advanced solid tumors (like lung or ov…

This clinical trial is testing an experimental oral medication called JAB-30355 for adults with advanced solid tumors that have a specific genetic mutation called TP53 Y220C. The study aims to determine the safest dose and see if the drug can shrink tumors in patients who have al…

This study is testing a new oral drug, JAB-23E73, designed to block a common cancer-driving protein called KRAS. It aims to find a safe dose and see if the drug can shrink tumors in 334 adults with advanced solid tumors that have a KRAS gene change. The trial is in early phases, …

This study is testing a new oral drug called JAB-23E73 for adults with advanced solid tumors that have a specific genetic change called a KRAS alteration. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. It is for people whose cancer …

This early-stage study is testing a new oral medication called JAB-2485 in adults with advanced solid tumors that have stopped responding to standard treatments. Researchers will first determine the safest dose and then look for early signs that the drug can shrink tumors in spec…